| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |